Get a never before seen look at the chronic myeloid leukemia (CML) program in Tanzania! Over 20 years ago, we partnered with local healthcare professionals to provide treatment access for people living with cancer – at no cost to them, for as long as they need
it.
Africa Region Head Cathy Scheepers takes you to clinics in Moshi and Dar es Salaam, talking with patients, advocates, and physicians about their progress and how we can reach more people living with CML.
Stay tuned for more behind-the-scenes videos! Cathy and the Max team will be visiting several countries this year, including Lesotho, Kenya, Malawi, Sierra Leone, and Ethiopia.
Join our email list for updates and follow along on social media to join the conversation.
The Max Foundation is a leading global health nonprofit organization dedicated to accelerating health equity. For 28 years, Max has pioneered practical, scalable, high-quality solutions to bring life-extending treatments and patient-centered health care to more than 100,000 people living with cancer and critical illness in low- and middle-income countries. Max believes in a world where all people can access high-impact medicines, where geography is not destiny, and where everyone can strive for health with dignity and with hope.
Setu Kumari Khadka was born in Nepal in 1989 to much celebration, as the first daughter born into her family after several generations. Setu remembers being weak and having health issues as a child and having to be taken to Mumbai, India for diagnosis and hospitalized there. No cause for her weakness came out of….
Finding effective treatment is difficult for people living with cancer in low- and middle-income countries. It can take years to start feeling better. Christian, called Tian by his loved ones, works as a medical technologist at a private hospital in the Philippines. He was diagnosed with chronic myeloid leukemia (CML) in 2012, when he was….
For people living with chronic myeloid leukemia (CML), regular disease monitoring using polymerase chain reaction (PCR) testing is critical to achieving successful health outcomes. Mutation testing is another key test for individuals who fail to respond to one or more treatments. Despite the importance of these tests, they are unaffordable and therefore inaccessible for many people living with CML in the Philippines.
